v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Total revenue $ 4,420 $ 132,014 $ 7,248 $ 132,064
Operating expenses:        
Research and development 40,517 57,510 91,328 121,624
General and administrative 15,910 16,127 33,508 33,591
Restructuring costs 32,609 0 32,609 0
Total operating expenses 89,036 73,637 157,445 155,215
Income (loss) from operations (84,616) 58,377 (150,197) (23,151)
Other income (expense):        
Interest income 3,794 6,521 8,142 13,686
Other expense, net (143) (51) (283) (128)
Total other income, net 3,651 6,470 7,859 13,558
Income (loss) before income taxes (80,965) 64,847 (142,338) (9,593)
Provision for (benefit from) income taxes 44,802 (2,039) 43,624 (4,240)
Net Income (Loss) $ (125,767) $ 66,886 $ (185,962) $ (5,353)
Basic (in dollars per share) $ (2.34) $ 1.24 $ (3.45) $ (0.10)
Diluted (in dollars per share) $ (2.34) $ 1.22 $ (3.45) $ (0.10)
Weighted-average ordinary shares outstanding used in per share calculations- basic (in shares) 53,827 53,767 53,827 53,740
Weighted-average ordinary shares outstanding used in per share calculations- diluted (in shares) 53,827 55,043 53,827 53,740
Collaboration revenue        
Total revenue $ 4,420 $ 132,014 $ 7,198 $ 132,014
Revenue from license and intellectual property        
Total revenue $ 0 $ 0 $ 50 $ 50